MRI-guided adaptive high-dose rate brachytherapy (HDR) has become the standard of care for patients with locally advanced cervical cancer. Those patients with parametrial invasion or bladder or rectum invasion need combined interstitial / intracavitary brachytherapy for an adequate dose to the tumor without increasing the rectum and bladder doses.